Concepedia

Author

Mavis Mensah

Fondazione IRCCS Istituto Nazionale dei TumoriORCID

Also Known As

M Mensah, M. Mensah, Mavis Mensah, Mavis O Mensah, Mavis O. Mensah, Mavis Osipi Mensah, Mensah Mavis

43

Publications

502

Citations

11

H-Index

28

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei TumoriIstituto Giannina Gaslini
MM

About

Mavis Mensah is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in lung cancer, tumor microenvironment, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

143

2

Engineering

1

1

74

3

Health Sciences

1

1

25

4

Biostatistics

1

1

74

5

Cell Biology

1

1

25

Mavis Mensah

×

12

Publications

485

Citations

11

H-Index

YearCitations

Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study

Mattia Boeri, Massimo Milione, Claudia Proto,

Clinical Cancer Research

2019

81

Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction

Orazio Fortunato, Mattia Boeri, Massimo Moro,

Cell Death and Disease

2014

78

Assessment of Circulating microRNAs in Plasma of Lung Cancer Patients

Orazio Fortunato, Mattia Boeri, Carla Verri,

Molecules

2014

74

Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer

Francesca Andriani, Elena Landoni, Mavis Mensah,

BMC Cancer

2018

52

MiR-16 regulates the pro-tumorigenic potential of lung fibroblasts through the inhibition of HGF production in an FGFR-1- and MEK1-dependent manner

Francesca Andriani, Maria Teresa Majorini, Miguel Mano,

Journal of Hematology & Oncology

2018

34

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

Mavis Mensah, Cristina Borzi, Carla Verri,

Journal of Visualized Experiments

2017

33

Cotargeting of miR‐126‐3p and miR‐221‐3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling

Daniela Di Paolo, Francesca Pontis, Massimo Moro,

Molecular Oncology

2021

32

Circulating extracellular vesicles from individuals at high-risk of lung cancer induce pro-tumorigenic conversion of stromal cells through transfer of miR-126 and miR-320

Francesca Pontis, Luca Roz, Mavis Mensah,

Journal of Experimental & Clinical Cancer Research

2021

28

MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway

Massimo Moro, Orazio Fortunato, Giulia Bertolini,

Pharmaceuticals

2022

25

Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma

Patrizia Gasparini, Orazio Fortunato, Loris De Cecco,

Cancers

2019

24

Page 1